CA3, carbonic anhydrase 3, 761

N. diseases: 37; N. variants: 4
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0019193
Disease: Hepatitis, Toxic
Hepatitis, Toxic
0.500 Biomarker disease CTD_human Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model. 25231249 2015
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.500 Biomarker phenotype CTD_human Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model. 25231249 2015
CUI: C1262760
Disease: Hepatitis, Drug-Induced
Hepatitis, Drug-Induced
0.500 Biomarker disease CTD_human Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model. 25231249 2015
CUI: C3658290
Disease: Drug-Induced Acute Liver Injury
Drug-Induced Acute Liver Injury
0.500 Biomarker disease CTD_human Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model. 25231249 2015
Chemical and Drug Induced Liver Injury
0.500 Biomarker disease CTD_human Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model. 25231249 2015
CUI: C4279912
Disease: Chemically-Induced Liver Toxicity
Chemically-Induced Liver Toxicity
0.500 Biomarker disease CTD_human Characteristic molecular and proteomic signatures of drug-induced liver injury in a rat model. 25231249 2015
CUI: C0019193
Disease: Hepatitis, Toxic
Hepatitis, Toxic
0.500 Biomarker disease CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
CUI: C0023893
Disease: Liver Cirrhosis, Experimental
Liver Cirrhosis, Experimental
0.500 Biomarker disease CTD_mouse Systems level analysis and identification of pathways and networks associated with liver fibrosis. 25380136 2014
CUI: C0860207
Disease: Drug-Induced Liver Disease
Drug-Induced Liver Disease
0.500 Biomarker phenotype CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
CUI: C1262760
Disease: Hepatitis, Drug-Induced
Hepatitis, Drug-Induced
0.500 Biomarker disease CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
CUI: C3658290
Disease: Drug-Induced Acute Liver Injury
Drug-Induced Acute Liver Injury
0.500 Biomarker disease CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
Chemical and Drug Induced Liver Injury
0.500 Biomarker disease CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
CUI: C4279912
Disease: Chemically-Induced Liver Toxicity
Chemically-Induced Liver Toxicity
0.500 Biomarker disease CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
CUI: C0023893
Disease: Liver Cirrhosis, Experimental
Liver Cirrhosis, Experimental
0.500 Biomarker disease CTD_human Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis. 17072980 2006
CUI: C0028754
Disease: Obesity
Obesity
0.310 Biomarker disease BEFREE Carbonic anhydrase III (Car3) is not required for fatty acid synthesis and does not protect against high-fat diet induced obesity in mice. 28437447 2017
CUI: C0028754
Disease: Obesity
Obesity
0.310 Biomarker disease CTD_human Orchestrated downregulation of genes involved in oxidative metabolic pathways in obese vs. lean high-fat young male consumers. 20882379 2011
CUI: C0004681
Disease: Bagassosis
Bagassosis
0.300 Biomarker disease CTD_human Pathway analysis for a genome-wide association study of pneumoconiosis. 25445010 2015
CUI: C0032273
Disease: Pneumoconiosis
Pneumoconiosis
0.300 Biomarker disease CTD_human Pathway analysis for a genome-wide association study of pneumoconiosis. 25445010 2015
CUI: C0015695
Disease: Fatty Liver
Fatty Liver
0.210 AlteredExpression disease BEFREE We observed lower protein levels of Car3 in high-fat diet fed mice treated with niclosamide, a drug published to improve fatty liver symptoms in mice. 28437447 2017
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.210 AlteredExpression disease BEFREE We observed lower protein levels of Car3 in high-fat diet fed mice treated with niclosamide, a drug published to improve fatty liver symptoms in mice. 28437447 2017
CUI: C0015695
Disease: Fatty Liver
Fatty Liver
0.210 Biomarker disease CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
CUI: C2711227
Disease: Steatohepatitis
Steatohepatitis
0.210 Biomarker disease CTD_mouse Characterization of chemically induced liver injuries using gene co-expression modules. 25226513 2014
CUI: C0019207
Disease: Hepatoma, Morris
Hepatoma, Morris
0.200 Biomarker disease CTD_mouse Expression profiling and identification of novel genes in hepatocellular carcinomas. 11420682 2001
CUI: C0019208
Disease: Hepatoma, Novikoff
Hepatoma, Novikoff
0.200 Biomarker disease CTD_mouse Expression profiling and identification of novel genes in hepatocellular carcinomas. 11420682 2001
CUI: C0023904
Disease: Liver Neoplasms, Experimental
Liver Neoplasms, Experimental
0.200 Biomarker phenotype CTD_mouse Expression profiling and identification of novel genes in hepatocellular carcinomas. 11420682 2001